We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HEIA:EURONEXT AMSTERDAMHeineken NV Analysis

Data as of 2026-03-10 - not real-time

CA$9.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ~9.9 CAD, comfortably below its 20‑day SMA of 10.79 and the identified support level of 10.29. This price gap signals a technical pull‑back despite a broader bullish trend indicated by SMA20 > SMA50 > SMA200. Momentum is extreme, with the RSI perched at 81.8, flagging overbought conditions. The MACD histogram is negative and the signal line is bearish, confirming short‑term downside pressure. Volatility remains elevated at over 26% on a 30‑day basis, while average volumes have been dwindling, pointing to a liquidity squeeze. Fundamentally, the company reports a trailing PE of only 1.87 and a DCF‑derived fair value near 2.42, suggesting the market price is materially above intrinsic estimates. Revenue has contracted by 2.8% YoY and debt‑to‑equity sits near 94%, raising concerns about balance‑sheet resilience. The firm carries no dividend, so income‑oriented investors receive no yield. Nonetheless, the business operates in the defensive beverages sector, which historically cushions earnings during economic slowdowns. The Fear & Greed Index reads “Extreme Greed,” indicating that market sentiment may be overly optimistic.
Given these mixed signals, the near‑term outlook leans cautious while the longer horizon retains a value‑oriented appeal.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below support and SMA20
  • Overbought RSI and bearish MACD
  • Decreasing volume and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Defensive sector fundamentals
  • Negative revenue growth but stable operating margins
  • Elevated market sentiment may correct

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant discount to DCF fair value
  • Low PE indicating potential value upside
  • Global brand diversification providing resilience

Key Metrics & Analysis

Financial Health

Revenue Growth-2.80%
Profit Margin6.56%
P/E Ratio1.9
ROE9.94%
ROA4.31%
Debt/Equity93.52
P/B Ratio0.2
Op. Cash FlowCA$5.0B
Free Cash FlowCA$2.1B

Technical Analysis

TrendBullish
RSI81.8
SupportCA$10.29
ResistanceCA$10.88
MA 20CA$10.79
MA 50CA$10.16
MA 200CA$9.80
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair ValueCA$2.42
GradeOvervalued
TypeValue

Risk Assessment

Beta-0.17
Volatility26.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.